Modulation of adaptive immunity with Toll-like receptors
- ,
- Bali Pulendran(corresponding author)
- Emory University
Scholary Output:
Contribution to journal
Review article
Peer-reviewOpen access
Sustainable Development Goals
- SDG 3 Good Health and Well
Abstract
The discovery of Toll-like receptors (TLRs), and their role in sensing infections represents one of the most seminal advances in immunology in recent years. It is now clear that TLRs play a fundamental role in innate recognition of microbes, and stimulate and tune the quality of the adaptive immune response. However, major knowledge gaps remain in our understanding of how TLRs regulate the development and persistence of T- and B-cell memory. Here, we review our current understanding of how TLR-signaling shapes the adaptive immune response, and highlight unanswered questions, the solution of which will be imperative in the rational exploitation of TLRs in vaccine design and immune therapy.
Publication Information
Output type
Scholary Output:
Contribution to journal
Review article
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 185-193 (9 pages)Journal (Volume, Issue Number)
Seminars in Immunology (Volume 21, Issue 4)Publication milestones
- Published - 08/2009
Publication status
Published - 08/2009
ISSN
1044-5323Publication IDs
- Scopus: 69949083414
- PubMed: 19502082
Publication metrics
Metrics
SciVal
citations
183
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
1
SciVal
FWCI
3.38
SciVal
Author count
2
SciVal
Paper percentile
98
SciVal
Top percentile
5
PlumX, opens in new tab
Captures
198
Citation count
221
Funding Details
We thank the generous support of the National Institutes of Health (grants R01 DK057665, R01 AI048638, U19 AI057266, U54 AI057157, N01 AI50019 and N01 AI50025) and the Bill & Melinda Gates Foundation.
FundersFunding numbers
NIH
U19 AI057266, R01 DK057665, R01 AI048638, U54 AI057157, N01 AI50019
NIAID
N01AI050025
BMGF
-